Wall Street brokerages expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings of $0.18 per share for the current quarter, according to Zacks. Nine analysts have made estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.17 and the highest estimate coming in at $0.20. Allscripts Healthcare Solutions reported earnings per share of $0.14 in the same quarter last year, which would suggest a positive year over year growth rate of 28.6%. The firm is expected to issue its next quarterly earnings results on Thursday, February 15th.
On average, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $0.62 per share for the current fiscal year, with EPS estimates ranging from $0.60 to $0.64. For the next financial year, analysts expect that the company will post earnings of $0.75 per share, with EPS estimates ranging from $0.72 to $0.80. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Allscripts Healthcare Solutions.
MDRX has been the subject of several research reports. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Cowen raised Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $13.00 to $16.00 in a research note on Monday, September 11th. Royal Bank of Canada initiated coverage on Allscripts Healthcare Solutions in a research note on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price target for the company. Jefferies Group set a $17.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Friday, August 25th. Finally, Maxim Group reiterated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $15.06.
In other news, SVP James Hewitt sold 36,796 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the completion of the transaction, the senior vice president now owns 181,766 shares of the company’s stock, valued at $2,564,718.26. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the transaction, the president now directly owns 1,351,773 shares of the company’s stock, valued at approximately $19,276,282.98. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 56,796 shares of company stock worth $804,842. 0.75% of the stock is currently owned by corporate insiders.
Institutional investors have recently made changes to their positions in the company. Wesbanco Bank Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 131.4% in the second quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock valued at $1,883,000 after buying an additional 83,807 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 1.0% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock valued at $72,033,000 after buying an additional 49,823 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Allscripts Healthcare Solutions by 26.9% in the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock valued at $117,026,000 after buying an additional 1,943,496 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 6.8% during the second quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock valued at $20,763,000 after purchasing an additional 103,395 shares during the last quarter. Finally, Royal Bank of Canada lifted its holdings in shares of Allscripts Healthcare Solutions by 53.3% during the second quarter. Royal Bank of Canada now owns 955,183 shares of the software maker’s stock valued at $12,189,000 after purchasing an additional 331,967 shares during the last quarter.
Allscripts Healthcare Solutions (MDRX) traded down $0.08 during trading on Tuesday, reaching $14.58. The company’s stock had a trading volume of 1,120,500 shares, compared to its average volume of 2,374,845. Allscripts Healthcare Solutions has a 12 month low of $10.19 and a 12 month high of $15.20. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20. The firm has a market capitalization of $2,652.40, a P/E ratio of -12.57, a P/E/G ratio of 2.61 and a beta of 1.34.
COPYRIGHT VIOLATION WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Expected to Announce Earnings of $0.18 Per Share” was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.thelincolnianonline.com/2018/01/14/allscripts-healthcare-solutions-inc-mdrx-expected-to-announce-earnings-of-0-18-per-share-updated-updated.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.